Cytarabin and daunorubicin or idarubicin in induction therapy of acute myeloid leukemia patients
Autor: | Eivazi-Ziaei, J., Kermani, I. A., Nikanfar, A., Maljaie, H., Mahmoudpour, A., Roya Dolatkhah, Golchin, M., Vaez, J. |
---|---|
Zdroj: | Scopus-Elsevier |
Databáze: | OpenAIRE |
Externí odkaz: |